A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and business, public, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 160 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 75 countries worldwide.

The Roscongress Foundation has Telegram channels in Russian (t.me/Roscongress), English (t.me/RoscongressDirect), and Spanish (t.me/RoscongressEsp). Official website and Information and Analytical System of the Roscongress Foundation: roscongress.org.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Andrey Kaprin

Andrey Kaprin

Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
Quotes
03.06.2021
SPIEF 2021
Digital Healthcare: Transparency, Efficiency, Quality
It [digitalization, Ed.] is currently more needed there [in regions, Ed.], because the shortage of staff is huge
04.09.2019
EEF 2019
A Step Forward for Healthcare in the Far East
Professionals in general are a complex problem all over the world, we see it now, especially with regard to morphology
04.09.2019
EEF 2019
A Step Forward for Healthcare in the Far East
We must understand that we have something to offer to our foreign colleagues. For example, we were the first in the world to do pancreatic cancer brachytherapy, which is of great interest now. Brachytherapy is still new in both People's Republic of China and in Japan, so they are ready to learn from us
05.09.2019
EEF 2019
International Cooperation in Science and Technology: Breakthrough Projects with Asia-Pacific Countries
We are a nuclear power, and it is a terrible shame to buy radionuclides. <...> For instance, having developed the yttrium-90 radionuclide treatment method for <...> metastatic liver disease, we will have to give up this method because we do not produce yttrium. <...> We do not produce any radiopharmaceuticals; our only output would be raw materials
07.06.2019
SPIEF 2019
Science and Life: The Boundaries of the Possible
Oncology is such a discipline where one must not even think about sanctions. Those who succeeded in making several steps forward should share them – we are fighting a common enemy
07.06.2019
SPIEF 2019
Science and Life: The Boundaries of the Possible
What are we dealing with? As of today, [our, – Ed.] institute has 8–10 medications that have gone through pre-clinical trial. There is not a single investor that would agree to invest a lot of money in a clinical trial. <…> We are being isolated from other countries, our scientists are isolated and lack human and financial resources
07.06.2019
SPIEF 2019
The Diseases of the Century. Can Cancer be Beaten?
Over the last 30 years, we have lost a lot in terms of human resources, technologies, outlook and the will of younger generation to follow this path. We need to restore all of it
06.06.2019
SPIEF 2019
The National Healthcare Project. Battling Non-communicable Diseases in Action
The ‘Medicine of the Future’ centre of innovative training programmes should become some sort of a backbone that will bring assistance to patients. What should a centre of innovative training programmes look like? It can be a cross-disciplinary point with cutting-edge equipment established at a multidisciplinary hospital. It should have a full range of equipment
06.06.2019
SPIEF 2019
The National Healthcare Project. Battling Non-communicable Diseases in Action
Many companies – including big ones – refuse: they are not ready for such a cash receipt procedure. They are unable to overhaul their supply system to provide us with [additional] medications
06.06.2019
SPIEF 2019
The National Healthcare Project. Battling Non-communicable Diseases in Action
We are talking about [higher longevity up to, – Ed.] 80+. There will be a lot more patients with cancers. How many of these patients will we be able to save despite their vascular diseases? What do we need to do to build up on our services to prepare them for elderly patients with cancers? We need to have an understanding for making the calculations, while aligning all these services
06.06.2019
SPIEF 2019
The National Healthcare Project. Battling Non-communicable Diseases in Action
The biggest objective is to introduce P4 [the concept based on the four principles – Predictive, Preventive, Personalized and Participatory, – Ed.]. in Russian regions
06.06.2019
SPIEF 2019
The National Healthcare Project. Battling Non-communicable Diseases in Action
It took [other] countries 60–70 years to come all this way. We have a totally different task. We have a clear instruction from the President of the Russian Federation to level off. This is an ambitios objective: 185 fatalities [from oncological diseases] per 100 thousand people
08.06.2019
SPIEF 2019
Priority Strategies in the Supply of Drugs
Laws need to become less stringent, and the tax burden must be reduced for those who are willing to enter clinical trials with us
08.06.2019
SPIEF 2019
Priority Strategies in the Supply of Drugs
The problem is that we get to the pre-clinical stage, finish that, and then everything stops there. There is not a single investor who will enter clinical trials with us
14.02.2019
Russian Investment Forum 2019
Science and Society: A Strategy for Future Generations
What do we lack? We lack coordination. The thing is that many leaders of research institutes are unaware that their laboratories conduct parallel research. I saw it first-hand when three research institutes were united under the organization I was entrusted to head
14.02.2019
Russian Investment Forum 2019
Science and Society: A Strategy for Future Generations
Unfortunately, science and clinical research in our country get little financing. We all know that in order to end up with a medication, you need to make an enormous down payment that needs to get a return – it is long-term money. We need to give it a good thought
13.02.2019
Healthy Life Forum: Towards 80+ 2019
Reducing Mortality from Non-Communicable Diseases: Implementing Federal Projects
The shortage of local staff is about 43%. Meanwhile, the functional centres are 96.6% staffed,
25.05.2018
SPIEF 2018
Science is Doing What Politics Cannot Do
Scientists are unlikely to overcome this barrier by themselves. <...> There needs to be the political will to open up the capabilities of laboratories, to allow an understanding of the entire logistics and movement chain. Essentially, this would be a shared international laboratory